EBITDA (including lease liabilities and license payable) was at 2.5x. Total equity was at Bt94,003mn, increasing 3.7% from increased retained earnings. Cash flow In 1H24, cash flow from operation (after
operation (after tax) reported at Bt53,918mn, increasing 42% compare to 1H23 following a improvement in EBITDA. Net cash outflow from investing was at Bt16,848mn and at Bt5,189mn for spectrum license. As a
operation calculated from two audited consolidated financial statements for a period of 9 months ending on 30 September 2018 of the Company. Once included the asset acquisition transaction(s) occurred during
profits from operation calculated from two audited consolidated financial statements for a period of 9 months ending on 30 September 2018 of the Company. Once included the asset acquisition transaction(s
. 1/2018. 2. Approved the appropriation and retaining of the net profit Baht 511 million as legal reserve and the declaration of dividend payment from the Company consolidated net profit for the period
. 1/2018. 2. Approved the appropriation and retaining of the net profit Baht 511 million as legal reserve and the declaration of dividend payment from the Company consolidated net profit for the period
of the year 2018 was at 90,047 trips/day representing an increase by 7.6 percent when compared to the same quarter of the previous year. Cost of service for operation of Expressway business consisted
Ended December 31, 2018 To The President The Stock Exchange of Thailand Management Discussion and Analysis Consolidated Financial Statements For Financial Year ended December 31, 2018 Overall Group
Public Company Limited and its subsidiaries would like to notify the operating results stated in consolidated financial statements for the year 2019. The details as follows: The Structure of Revenues R&B
, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Consolidated For the Year Ended December 31 2019 2018 MB % MB % Total revenues 375.89 100.00 317.58 100.00